7月31日，劲方医药-B盘中上涨5.45%，报28.24港元/股，成交额2757.3万港元。
劲方医药-B所在的生物科技行业中，个股中，信达生物跌0.06%，康方生物涨2.09%，百济神州跌0.61%，三生制药跌2.3%，科伦博泰生物涨1.7%。
劲方医药科技（上海）有限公司是一家专注于创新药物研发的中国公司，主要为肿瘤、自身免疫性疾病和炎症性疾病提供新型治疗方案，研发平台涵盖靶点发现、分子发现与评估、转化科学和临床开发等环节。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.